The earnings release is largely procedural given the pending Merck KGaA acquisition. The stock's near-term path is tied to deal closing conditions and regulatory approvals, not quarterly operating performance. Monitor for shareholder vote dates and regulatory clearance milestones.
Price Chart
Executive Summary
Bio-Techne reported Q4 FY2026 adjusted EPS of $0.52, a 2.1% beat vs $0.52 consensus, on revenue of $321.2M (1% reported growth, 3% organic). Full-year revenue was flat at $1.2B. The results are largely procedural given the pending $73/share acquisition by Merck KGaA, with the company no longer holding earnings calls. The modest adjusted EPS decline and flat revenue are secondary to the deal's trajectory and premium.
Key Financial Metrics
Key Facts
- Q4 FY2026 revenue $321.2M, +1% reported / +3% organic vs prior year
- Adjusted EPS $0.52 vs $0.53 a year ago, beating consensus of $0.52
- GAAP EPS $0.35 vs $(0.11) a year ago, driven by prior-year impairment
- Full-year FY2026 revenue flat at $1.2B; adjusted EPS $1.93 vs $1.92
- Pending acquisition by Merck KGaA at $73/share (~$11.3B EV) dominates stock trajectory
- Company no longer holding investor conference calls for quarterly results
Financial Impact
Q4 revenue $321.2M, adjusted EPS $0.52; full-year revenue $1.2B, adjusted EPS $1.93
Risk Factors
- Acquisition by Merck KGaA may face regulatory delays or fail to close
- Flat full-year revenue and declining adjusted EPS signal limited organic growth momentum
- No forward guidance provided; uncertainty about standalone performance if deal fails
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302849060 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | 8-K | $72.23 $72.08 | ▼ −0.21% | ▲ +1.69% | $72.42 (+0.26%) |
Aug 12, 2026 7w ago | Press Release | $72.23 $72.08 | ▼ −0.21% | ▲ +1.69% | $72.42 (+0.26%) |
Aug 10, 2026 7w ago | PREM14A | $72.15 $72.25 | ▲ +0.14% | ▲ +1.20% | $72.42 (+0.37%) |
Jun 25, 2026 14w ago | DEFA14A | $71.00 $71.77 | ▲ +1.08% | ▼ −0.18% | $72.42 (+1.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access